相关实验视频
Updated: Jul 16, 2025

06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
22.6K
甘酸A向氨酸丰富的重复激酶2参与帕金森病-一项计算研究
1Department of Medical Elementology and Toxicology Jamia Hamdard University Delhi India.
Aging medicine (Milton (N.S.W))
|September 15, 2023
概括
光的化合物显示出治疗帕金森病 (PD) 的潜力. 甘酸A (GAA) 被确定为一个有前途的LRRK2抑制剂,需要进一步验证.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 计算化学的计算化学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病.
- LRRK2与PD的病变发生有关.
- 光 (Ganoderma lucidum) 具有各种不同的药用特性.
研究的目的:
- 为了确定有前途的Ganoderma lucidum化合物,针对PD中的LRRK2.
- 为了评估Ganoderma lucidum在神经疾病治疗中的潜力.
主要方法:
- 对五种Ganoderma lucidum化合物的ADMET分析.
- 分子对接模拟. 分子对接模拟.
- 分子动力学模拟.分子动力学模拟.
- MMGBSA 的计算.
主要成果:
- 甘酸A (GAA) 成为最有前途的化合物.
- GAA显示了针对LRRK2.2的显著潜力.
结论:
- 甘酸A (GAA) 是PD的潜在治疗候选物.
- 需要进一步的体外和体内研究来验证GAA的疗效.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.6K
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
15.2K
相关概念视频
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K